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Objective: Although the majority of the adenosine triphosphate (ATP) in chondrocytes is made by
glycolysis rather than by oxidative phosphorylation in mitochondria there is evidence to suggest that
reactive oxygen species produced by mitochondrial electron transport (ET) help to maintain cellular
redox balance in favor of glycolysis. The objective of this study was to test this hypothesis by determining
if rotenone, which inhibits ET and blocks oxidant production inhibits glycolytic ATP synthesis.
Design: Bovine osteochondral explants were treated with rotenone, an ET inhibitor; or oligomycin an ATP
synthase inhibitor; or 2-ﬂuoro-2-deoxy-D-glucose, a glycolysis inhibiter; or peroxide, an exogenous
oxidant; or mitoquinone (MitoQ), a mitochondria-targeted anti-oxidant. Cartilage extracts were assayed
for ATP, nicotine adenine dinucleotide (NADþ/H), and culture medium was assayed for pyruvate and
lactate after 24 h of treatment. Imaging studies were used to measure superoxide production in cartilage.
Results: Rotenone and 2-FG caused a signiﬁcant decline in cartilage ATP (P < 0.001). In contrast, ATP
levels were not affected by oligomycin. Peroxide treatment blocked rotenone effects on ATP, while
treatment with MitoQ signiﬁcantly suppressed ATP levels. Rotenone and 2-FG caused a signiﬁcant
decline in pyruvate, but not in lactate production. NADH:NADþ ratios decreased signiﬁcantly in both
rotenone and 2-FG-treated explants (P < 0.05). Rotenone also signiﬁcantly reduced superoxide
production.
Conclusions: These ﬁndings showing a link between glycolysis and ET are consistent with previous
reports on the critical need for oxidants to support normal chondrocyte metabolism. They suggest
a novel role for mitochondria in cartilage homeostasis that is independent of oxidative phosphorylation.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Biosynthetic activity required for the maintenance and repair of
the articular cartilage extracellular matrix (ECM) draws heavily on
chondrocyte energy stores and ECM synthesis rates are closely tied
to the availability of adenosine triphosphate (ATP)1e3. ECM
synthesis increases when cartilage is damaged by mechanical
injury, increasing the demand for ATP4. Thus, inadequate ATP
production has the potential to undermine repair activities that
counter cartilage degeneration5,6.
Articular cartilage chondrocytes harbor relatively few mito-
chondria compared with most other cell types7 and may not
express all subunits of the mitochondrial electron transport (ET)
chain8. Moreover, ET is impaired by low oxygen levels in the
cartilage matrix1. As a result, less than 10% of total cellular ATP is
derived from oxidative phosphorylation and the remainder is.A. Martin, 500 Newton Road,
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rtin).
s Research Society International. Pproduced largely via the Embden-Meyerhof glycolysis pathway9.
Nevertheless, mitochondrial damage and dysfunction has been
implicated in primary and post-traumatic osteoarthritis10e13,
indicating that mitochondria play important roles in cartilage
physiology despite their minimal ATP-generating capacity.
However, precisely how mitochondria function in chondrocyte
metabolism is still somewhat obscure.
Our recent work showed that mitochondria are a principle
source of reactive oxygen species released by chondrocytes in
response to blunt impact injuries13. That study showed that treat-
ment with rotenone, an inhibitor of complex I of the mitochondrial
ET chain, prevented reactive oxygen species (ROS) release and
chondrocyte death after impact. Although in that context ROS were
produced at lethal levels, it remains possible that at lower levels,
ROS produced by mitochondrial might play a role in normal physi-
ology. In cartilage, ROS have been extensively studied in terms of
their role in the pathogenesis of OA; however, low, sub-lethal ROS
levels appear to have beneﬁcial effects and are important for carti-
lage homeostasis14,15. Extracellular superoxide and hydrogen
peroxide activate the mitogen activated kinases extracellularublished by Elsevier Ltd. All rights reserved.
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regulate catabolic and anabolic gene expression15. Treatment of
chondrocytes with sub-lethal doses of hydrogen peroxide sup-
pressed interleukin-1- and lipopolysaccharide-induced increases in
the expression of pro-inﬂammatory mediators such as nitric oxide
synthase16. Furthermore, cartilage explants conditioned by
repeated peroxide treatment were protected from apoptosis and
other harmful effects of mechanical compression through up-
regulation of catalase gene expression and down regulation of
matrix metalloprotease-317. While nicotine adenine dinucleotide
phosphate (NADPH) oxidase has been thought to be the primary
source of superoxide in cartilage15, our work suggests that mito-
chondria also play an important role.
Results published by Lee and Urban revealed that oxygen or
other electron acceptors support glycolysis in articular cartilage.
Their initial ﬁndings showed a negative Pasteur Effect whereby ATP
and lactate production in cartilage declined sharply under anoxic
conditions1. Subsequently they showed that anaerobic glycolysis
was rescued by providing exogenous oxidants, which appeared to
maintain redox balance in chondrocytes exposed to anoxic or
severely hypoxic conditions18. In the light of these studies we
propose that ROS released by mitochondria might constitute
a natural source of oxidants that supports glycolytic ATP synthesis
in chondrocytes. This mechanism might be particularly important
following joint injury, when damage to the cartilage matrix stim-
ulates demand for de novo matrix production at a time when
ambient oxygen levels have dramatically declined19.
Based on the ﬁndings summarized above we hypothesized that
cytosolic glycolysis and mitochondrial ET are coupled. To test this,
we measured tissue-level ATP, nicotine adenine dinucleotide
(NADþ/H), and pyruvate levels in bovine cartilage treated with
inhibitors of glycolysis, ET, and oxidative phosphorylation. Osteo-
chondral explants were treated with rotenone which inhibits
mitochondrial ET at complex I (NADH dehydrogenase)20; or with
oligomycin, which inhibits mitochondrial oxidative phosphoryla-
tion at complex V (ATP synthase)21, or with 2-ﬂuoro-2-deoxy-D-
glucose (2-FG) which inhibits hexokinase at the initial step of
glycolysis, or with mitoquinone (MitoQ), a free radical scavenger
targeted to mitochondria22e24; or with tertiary butyl hydroper-
oxide (tBHP), a stabilized form of hydrogen peroxide. Effects of the
inhibitors on cell viability and the effects of rotenone on superoxide
production were also measured.
Methods
Metabolic inhibitors including rotenone, oligomycin, and 2-
ﬂuoro-2-deoxy-glucose and tBHP were purchased from Sigma
Chemicals (St Louis, MO). MitoQ was a kind gift from Dr. Michel
Murphy via Dr. Douglas Spitz of theUniversity of IowaDepartment of
Radiology. Dihydroethidium (DHE) and calcein AM were purchased
from Invitrogen (Carlsbad, CA). Bovine stiﬂe joints were obtained
from a local abattoir. Osteochondral explants (2.5 cm 2.5 cm) were
excised from the tibial plateau and placed immediately in Hanks
balanced salt solution (HBSS). Explants were then transferred to low
glucose culture medium (45% low glucose Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM), 45% Ham’s F-12, 10% fetal calf serum, 0.1%
Fungizone, 0.05% Pen-Strep) and incubated at 37C in an atmosphere
consisting of 5% oxygen, 80% nitrogen, and 5% carbon dioxide.
Following excision and 24 h of incubation in culture medium,
three experimental groups of were treated with one of the three
metabolic inhibitors at doses previously shown to be effective:
0.625, 2.5, 10 mM rotenone13, 2.5, 5, 10 mM oligomycin25, or 0.5, 1,
3 mM 2-FG13,26,27. A fourth experimental group was treated with
a combination of 2-FG (1 mM) and oligomycin (5 mM). A ﬁfth group
was treated with MitoQ (4 mM). A sixth group was treated withtBHP alone (250 mM) and a seventh group was treated with
a combination of tBHP (250 mM) and rotenone (2.5 mM). Treatments
were continued for 24 h prior to metabolite assays. Six untreated
explants served as controls.
The method for measuring ATP production in bovine chon-
drocytes was adapted from a method used to quantify ATP
concentrations in spermatozoa28. Directly following harvest, 6-mm
cartilage plugs were weighed (40e60 mg) and placed in 0.5 ml
water containing a phosphatase inhibitor cocktail (sodium vana-
date, sodium molybdate, sodium tartrate, and imidazole) diluted
1:100 as directed by the manufacturer (Sigma P5726). The tubes
containing cartilage plugs were then placed into boiling water for
10 min to extract ATP. The extract was centrifuged (12,000 g, 5 min)
to pellet debris. ATP levels in supernatants were assayed using
a commercial kit (Sigma FLAA ATP Bioluminescent assay kit). The
luminescence of samples and standards wasmeasured using a 1450
MicroBeta TriLux Microplate Scintillation and Luminescence
Counter. Each sample or standard was assayed in triplicate. Results
are reported in nmol ATP/mg cartilage.
In separate specimens, the effects of the metabolic inhibitors on
cell viability were assessed after a 24 h treatment period. Calcein
AM (1mM)was used to stain viable cells and ethidium homodimer-
2 (1 mM) was used to detect dead cells (Invitrogen Molecular
Probes) as previously described29. Samples were scanned to a depth
of 200 mm in 20 mm intervals. At each 20 mm interval, viable (green)
and nonviable (red) chondrocytes were counted. Image J software
was used to determine the average percentage of viable cells for
each of the metabolic inhibitor treatment groups.
DHEwas used as a probe for superoxide production as described
previously13. Brieﬂy, untreated explants or explants treated with
2.5 mM rotenone for 2 h were stained with DHE and calcein AM
(Invitrogen) for 30 min. The explants were scanned with a BioRad
1024 confocal microscope (BioRad, CA). Images were analyzed
using a custom computer algorithm to count DHE and Calcein AMe
positive cells in three 20 ﬁelds on each explant. Results are
reported as the percentage of DHE positive cells (DHE stained/DHE-
stained þ Calcein AM stained).
NADþ and NADH were measured using a ﬂuorometric assay kit
(Fluoro NAD) according to the supplier’s protocol (Cell Technology
Inc.). Two experimental groups (six explants per group) were
treated for 24 h with either rotenone or 2-FG. Six untreated
explants served as controls. Cartilage plugs (6 mm diameter, w2
mm-thick) were bisected and each half weighed (20e30 mg). After
rinsing in cold phosphate buffered saline the samples were chop-
ped in cold NAD or NADH lysis buffer (200 ml) and homogenized
using a Polytron device with a 5 mm standard generator. The
homogenates were heated to 60C for 15 min then cooled to 4C.
One-hundred ml of the reaction buffer was added followed by 200 ml
of the opposite extraction buffer to neutralize the homogenates.
The tubes were vortexed and centrifuged (8000 g) for 5 min. 50 ml
of each sample supernatant or standard were mixed with 100 ml
reaction cocktail in a black-bottomed 96-well plate (Nunc).
A SpectraMax M5 microplate ﬂuorometer (Molecular Devices) was
used to measure ﬂuorescence intensity (Excitation 565 nm, Emis-
sion 600 nm). Each sample was assayed in triplicate and the results
are reported as the ratio of NADH to NADþ.
Pyruvate and lactate were measured in explant culture media
using ﬂuorometric assay kits (BioVision) according to the manu-
facturer’s protocol. Experimental samples and untreated control
explants were incubated in 10 ml culture medium (45% low
glucose, pyruvate-free DMEM, 45% Ham’s F-12,10% fetal calf serum,
0.1% Fungizone, 0.05% Pen-Strep) for 24 h. Medium samples were
processed by ﬁltration using Microcon 3 kDa cutoff ﬁlters (Milli-
pore). Samples and lactate or pyruvate standards (50 ml) were
mixed with 50 ml reaction buffer in a black-bottomed 96-well
Table II
Effects of rotenone and 2-FG on lactate and pyruvate production in explants. Lactate
and pyruvate accumulation in culturemedia over 24 h was measured. Means (nmol/
mg) conﬁdence intervals (C.I.) are shown for lactate and pyruvate accumulation in
culture media over 24 h. P values are indicated. n ¼ 5 explants per group
Viable (%) C.I P value
Low High
Control 90 85 94 NA
Rotenone 87 81 93 0.58
Oligomycin 88 82 93 0.844
2-FG 90 84 96 0.448
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rescence intensity was measured in a SpectraMax M5 microplate
ﬂuorometer (excitation 535 nm, emission 570 nm). Results are re-
ported in mmol/L (mM). Each sample was assayed in triplicate.
Oxygen saturation levels were measured using a Thermo
Scientiﬁc biochemical oxygen demand (BOD) Probe. One gram of
bovine articular cartilage obtained from the femoral condyle was
used in each experiment. One bovine cheek muscle sample ob-
tained from the same abbatoir was also examined. Cartilage
samples were allowed to equilibrate to culture conditions (37C, 5%
CO2) in the previously described culture medium for 24 h. Muscle
samples were not allowed to equilibrate because of the rapid
spoilage rate of the tissue in culture conditions. Prior to testing, the
BOD probe was equilibrated to culture conditions for two h. Power
was applied to the probe for 1 h of this period to allow for complete
polarization. After 24 h of equilibration, samples were placed in
a BOD bottle (Hach Company) in 10 ml of culture medium with
treatment agents (if applicable), the probe was placed in the bottle,
and the bottle sealed with two layers of Paraﬁlm Laboratory Film
(American National Can). The blank control sample was tested with
only 10ml of culture media present in the bottle. Oxygen saturation
levels in the sealed bottle were read every 10 min for a total of 22 h
using an accumet excel XL40 Dissolved Oxygen Meter (Fisher
Scientiﬁc). Oxygen saturation levels are presented as a percentage
of initial oxygen concentration in the bottle.
Each explant was from a different animal. These were randomly
assigned to a treatment groups using a uniform random number
generator (SigmaPlot, Systat Software, San Jose CA). The means and
C.I.s reported are based on one measurement per explant. One-way
analysis of variance (ANOVA) on ranks with a post hoc Dunn’s test
for multiple comparisons was used for statistical analysis.
Results
The effects of various inhibitors on ATP are summarized in
Table I. Untreated control samples produced near 0.7 nmol ATP/mg
of tissuewhich decreased to varying degreeswith different doses of
rotenone or oligomycin. These effects were signiﬁcant for rotenone
and for 2-FG at the two highest doses. Oligomycin tended to
increase ATP but the effects were not statistically signiﬁcant.
A combination of oligomycin and 2-FG gave similar results as 2-FG
alone, indicating that the ATP remaining in the tissue when
glycolysis was blocked was not generated by complex V, the
mitochondrial ATPase inhibited by oligomycin. The mitochondria-Table I
Effects of metabolic inhibitors on the ATP content of articular cartilage. ATP (nmol/
mg) was measured in cartilage from explants treated for 24 h with various drugs at
the concentrations indicated. Group means, conﬁdence intervals (C.I.), and P values
are shown. Each group is represented by ﬁve explants
Dose (mM) Mean C.I. P value
High Low
Control 0 0.695 0.766 0.625 NA
Rote 0.625 0.439 0.560 0.318 0.054
2.5 0.166 0.208 0.124 0.001
10 0.176 0.211 0.141 0.001
2-FG 0.5 0.436 0.631 0.241 0.017
1 0.085 0.104 0.066 0.001
3 0.037 0.045 0.029 0.001
Oligo 2.5 0.725 1.061 0.389 0.832
5 1.144 1.347 0.941 0.001
10 0.626 0.744 0.508 0.584
Oligo/2-FG 5/1 0.107 0.118 0.096 0.001
MitoQ 4 0.201 0.234 0.168 0.001
tBHP 250 0.898 1.049 0.747 0.081
tBHP/Rote 250/2.5 0.947 1.103 0.791 0.037targeted anti-oxidant MitoQ had a signiﬁcant suppressive effect
comparable in magnitude to that of rotenone, a result that shows
a link between mitochondrial oxidants and ATP. Like oligomycin,
the oxidant tBHP caused a slight increase that was not signiﬁcant at
the dose tested. However, tBHP appeared to block the inhibitory
effect of rotenone, indicating that an exogenous oxidant can be
substituted for oxidants produced by ET. At the dosages used in this
study none of the inhibitors were found to be cytotoxic: Cell
viability percentages in control specimens and the three treatment
groups were all approximately 90% (Table II).
The effects of rotenone (2.5 mM) on NADþ and NADH levels were
compared with the effects of 2-FG (1 mM) (Table III). Rotenone
reduced NADH levels by more than 4-fold compared with controls
while 2-FG reduced levels by more than 2-fold. Both drugs caused
signiﬁcant increases in NADþ (1.5 and 2.5-fold for rotenone and 2-
FG respectively). The NADH:NADþ ratio in untreated controls was
greater than 4, indicating that the bulk of the NAD in the cells was
in the reduced form (Fig. 1). Direct glycolysis inhibition with 2-FG
treatment reduced the NADH:NADþ ratio more than 2-fold to
less than 1.7, conﬁrming the central role of glycolysis in the
production of intracellular NADH from NADþ. Rotenone treatment
caused a ﬁve-fold decrease in the NADH:NADþ ratio. To some
degree, inhibitor effects on pyruvate production mirrored their
effects on NADH and NADþ (Table IV). Pyruvate concentrations in
control explant media averaged over 1.0 mM, compared to 0.39 and
0.45 mM respectively in rotenone- and 2-FG-treated explants. In
contrast, 2-FG and rotenone had no signiﬁcant effects on lactate
levels (Table IV).
The effects of rotenone on superoxide productionwere assessed
using DHE as a probe (Fig. 2). Treatment with 2.5 mM rotenone
reduced the number of cells stained with DHE from 9.3% to 4.2%.
This effect was signiﬁcant by t-test (P ¼ 0.019). Oxygen consump-
tion is expected to decline with oligomycin treatment, a conse-
quence of the eventual inhibition of ET as protons are prevented
from re-entering the mitochondrial matrix. To test for these effects
in our systemwe compared O2 consumption in untreated cartilage
and in cartilage treated with 5 mM oligomycin (Fig. 3). OligomycinTable III
Effects of rotenone and 2-FG treatment on NADH and NAD levels. The NADþ/NADH
content of tissue extracts was measured after 24 h treatments. Means (nmol/g) and
conﬁdence intervals (C.I.) and P values are given for each group. n ¼ 4 explants per
group
Mean (nmol/g) C.I. P value
Low High
NADH Control 4.029 3.425 4.633 N/A
2-FG 1.659 1.243 2.075 0.001
Rotenone 0.639 0.518 0.760 0.001
NADþ Control 0.956 0.794 1.118 N/A
2-FG 2.586 2.406 2.766 0.001
Rotenone 1.507 0.962 2.052 0.049
Fig. 1. Rotenone and 2-FG shifted the balance between the reduced and oxidized forms
of NAD. Treatment with rotenone or 2-FG caused highly signiﬁcant reductions in
NADH:NADþ ratios relative to untreated controls (*P ¼ 0.001). There was no difference
between the rotenone and 2-FG groups (P ¼ 0.749). Means þ/ conﬁdence intervals
(error bars) are based on four explants per group.
Fig. 2. Rotenone blocks oxidant production in cartilage. The graph shows the
percentage of DHE staining chondrocytes in control explants and in explants treated
with rotenone (2.5 mM). Means, conﬁdence intervals C.I. (error bars), and P value are
based on four explants per group.
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control samples for up to 12 h. Thereafter there was incomplete
recovery to near control values. These data conﬁrm that oligomycin
was effective in blocking complex V activity in our experiments.Discussion
Tissue-level ATP levels were assayed to determine chondrocyte
energy production from cells in their native matrix. If anything,
blocking oxidative phosphorylation by inhibiting ATP-synthase
with oligomycin had a slightly stimulatory effect on cartilage ATP
levels. Oxygen consumption experiments, which showed that
consumption was markedly reduced by oligomycin, conﬁrmed the
activity of the drug as used in our explant model. In contrast,
inhibiting hexokinase at the initial step of glycolysis with 2-FG
reduced ATP levels by up to several fold. Adding oligomycin to
specimens already treated with 2-FG resulted in no further
decreases in ATP, suggesting that the ATP remaining in cells treated
with 2-FG was not produced by oxidative phosphorylation. In situ
viability analysis revealed that none of the treatments were cyto-
toxic, conﬁrming that their effects on ATP content were due to
metabolic inhibition. These results agreed with those of other
investigators, which show that inhibitors of mitochondrial oxida-
tive phosphorylation, including uncouplers such as dinitrophenol
have minimal effects on ATP pools in cartilage1,30,31.
Given that neither oligomycin nor proton gradient uncouplers
such as dinitrophenol cause signiﬁcant depletion of cartilage ATP,
rotenone’s ability to deplete ATP and other metabolites was
surprising. ATP, pyruvate, and NADH:NADþ ratio in specimens
treated with rotenone were signiﬁcantly reduced nearly as much as
with 2-FG treatment. The large difference in NADH:NADþ ratios
between rotenone-treated explants and controls was due to lowerTable IV
Effects of metabolic inhibitors on chondrocyte viability. Means, conﬁdence intervals
C.I. (error bars), and P values for each group are based on three explants. Viability
was not signiﬁcantly affected by treatment with any of the metabolic inhibitors
Mean (mM) C.I. P value
Low High
Pyruvate Control 1.095 0.899 1.291 N/A
2-FG 0.392 0.344 0.440 0.001
Rotenone 0.447 0.287 0.607 0.001
Lactate Control 0.065 0.041 0.089 N/A
2-FG 0.034 0.027 0.042 0.049
Rotenone 0.069 0.091 0.048 0.751NADH levels together with higher NADþ levels in treated the
explants. These data are partially consistent with inhibition of
glycolysis, which could plausibly deplete NADH. However it is
unclear why NADþ levels increased above control levels with
rotenone, which blocks NADH dehydrogenase.
Assays revealed no signiﬁcant treatment effects on lactate levels
in this system. This together with the signiﬁcant suppression of
pyruvate by the drugs suggests that a greater proportion of the
available pyruvate was converted to lactate in treated cells than in
controls.
Our recent ﬁnding that rotenone blocks superoxide generation
by chondrocytes in injured cartilage13, and the ﬁndings reported
here that superoxide production is reduced by rotenone in non-
injured explants suggests that ET might inﬂuence glycolysis by
contributing oxidants that function in intracellular signaling or in
redox regulation. To investigate this hypothesis further we treated
explants with MitoQ, a cationic free radical scavenger that is tar-
geted to mitochondria22. This resulted in suppression of ATP to
levels seen with rotenone treatment. On the other hand, we found
that hydrogen peroxide blocked rotenone-induced reductions in
ATP, indicating that exogenous oxidants can substitute for free
radicals from ET. Although more deﬁnitive studies are needed,
these ﬁndings support the hypothesis that ET’s effects on glycolysis
are mediated by free radicals emitted by the ET chain. Interestingly,
the slight stimulatory effect of oligomycin, while difﬁcult to explain
in the light of its effectiveness at blocking oxygen consumption,
might be attributable to its stimulation of ET-related free radical
production32.
In addition to NADPH oxidase, the mitochondrial ET chain
appears to be a primary source of ROS in chondrocytes33,34.
Superoxide is generated by high-energy electrons that escape from
a series of bound complexes within the inner mitochondrial
membrane. Complexes I and III of the ET chain are the most active
superoxide generating sites and production from both sites is
signiﬁcantly reduced by Complex I inhibitors such as rotenone35,36.
ROS from mitochondrial act as physiologic transduction sig-
nals37e40. Milner et al. reported that ROS generated mainly by
Complex III regulate intracellular pH through effects on a Naþ/Hþ
transporter34. In human umbilical vein endothelial cells subjected
to repetitive cyclical strain, concentrations of mitochondrial ROS
increased signiﬁcantly together with robust increases in the
expression of several cell adhesion markers. These responses were
Fig. 3. Effect of oligomycin on oxygen consumption in cartilage explants. (A) Oxygen consumption by three untreated control cartilage samples (blue symbols) and three cartilage
samples treated with 5 mg/ml oligomycin (green symbols). A negative control consisting of culture medium with no tissue (cyan symbols) and a positive control consisting of bovine
skeletal muscle (black symbols) are also shown. (B) Group means and standard deviations at each time point are shown for untreated control samples and oligomycin treated samples.
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drial ROS were important intracellular signals that affected gene
and protein expression.
Evidence that oxidants play a supportive role in cartilage ATP
synthesis was ﬁrst reported by Lee and Urban. They demonstrated
a negative Pasteur Effect whereby ATP and lactate production were
severely impaired under anoxic conditions1. Subsequently, the
authors tested the hypothesis that alternative electron acceptors
could be substituted for oxygen itself18. In that experiment, glucose
uptake and lactate production under anoxic conditions were
restored to near normal values by methylene blue; 2,6-
dichlorophenol-indophenol, or the iron (III) complex ferricyanide.
The authors suggested that the glycolytic cycle was slowed by
negative feedback from excessive accumulation of reduced
metabolites in the absence of oxygen, a condition that exogenous
oxidants alleviated. These observations raise the question of
whether chondrocytes themselves generate intracellular oxidants
as an adaptation to life in a state of intermittent moderate to severe
hypoxia41. The rotenone effects we observed suggest that ET plays
such role.
Therewere several limitations to this study. First, we cannot rule
out the possibility that rotenone and/or 2-FG were selectively toxicto chondrocytes of the deeper zones, which were not visible by the
in situ method used to evaluate viability. Furthermore, depth-
dependent variation in mitochondrial function25 may have led to
depth-dependent inhibitor responses, a complexity that our bulk
assays would have missed. Second, we chose to normalize our data
to wet tissue mass, a reliable and well accepted measurement, but
one that assumed consistent viable cell density. This was conﬁrmed
in part by our imaging studies, which showed that the average
viability for all explants was 90% with a standard deviation only
6.3%. DNA was not used for normalization because neither ﬂuoro-
metric nor histologic assays discriminate between live cell DNA and
the DNA of dead cells, which persists in the matrix for several days
post-mortem42.
A growing body of evidence implicates mitochondrial dysfunc-
tion in osteoarthritis10e12,43e45 ET through complexes II and III of
the mitochondrial ET chain is impaired while overall mitochondrial
mass is increased in osteoarthritic cartilage. Larger numbers of
swollen mitochondria with subnormal membrane potential are
observed and these changes are associated with chondrocyte
apoptosis45. Membrane depolarization brought on by calcium
release provoked apoptosis in response to mechanical injury10. OA
is associated with reduced expression of manganese-superoxide
J.A. Martin et al. / Osteoarthritis and Cartilage 20 (2012) 323e329328dismutase (SOD2) in superﬁcial zone chondrocytes12 and oxidative
damage to mitochondrial DNA11. In addition, previous work in our
laboratory revealed that mitochondrial-derived ROS play a central
role in acute chondrocyte death induced by mechanical injury to
cartilage explants, an effect that may play an important role in the
pathogenesis of post-traumatic OA. Taken together these ﬁndings
indicate that mitochondria in particular and oxidative damage in
general play key roles in the pathogenesis of OA.
In summary, our ﬁndings reveal a vital, if indirect role for
mitochondria in chondrocyte energy production that focuses on
mitochondrial ET as a source of oxidants to maintain redox balance
under the predominantly reducing intra-articular environment.
This suggests that subtle changes in mitochondrial ET function
could undercut metabolic support for cartilage homeostasis long
before overt cartilage degeneration is apparent. Such metabolic
derangement, measurable as abnormalities in metabolite pools,
may ultimately serve as a prognostic biomarker for OA. Our results
also suggest that oxidants may be used therapeutically to restore
redox balance and support cartilage metabolism under conditions,
such as after articular injury when intra-articular oxygen reaches
critically low levels19,46,47.
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